SMAD2 and myelodysplastic syndrome: The ineffective erythropoiesis typical of MDS has been linked to Smad2/3 signaling in response to increased levels of transforming growth factor (TGF)-ß family ligands, including growth differentiation factors (GDFs), activins, bone morphogenic proteins (BMPs), and TGF-β [5, 6].